Synthesis and application of an alcohol amine with an extended main carbon chain are provided, belonging to the field of chemical building materials. Under the action of a catalyst, tertiary amine is subjected to a two-step substitution reaction, a hydrolytic reaction and a reducing reaction to obtain a novel alcohol amine (NAA). The novel alcohol amine as provided may have a better grinding aid effect than triethanolamine while is added into cement as a cement grinding aid, and thus has a wide application prospect.

Described are compositions and methods for inhibiting polymerization of a monomer (e.g., styrene) composition a quinone methide polymerization retarder and an ammonium salt. In a mixture, the ammonium salt improves the efficacy of the quinone methide polymerization retarder and provides greater antipolymerant activity. In turn, the mixture reduces or prevents apparatus fouling and improves the purity of monomer streams.

The present invention relates to a process for preparing alkanolamines and/or ethyleneamines in the liquid phase, by reacting ethylene glycol and/or monoethanolamine with ammonia in the presence of an amination catalyst comprising Co, Ru and Sn.

The present invention relates to a process for preparing alkanolamines and/or ethyleneamines in the liquid phase, by reacting ethylene glycol and/or monoethanolamine with ammonia in the presence of an amination catalyst comprising Co, Ru and Sn.

Disclosed are methods for separating, recovering, and purifying tetrahydrocannabinolic acid (THCA) salts from an organic solvent solution comprising a mixture of cannabinoids. The methods comprise solubilizing the mixture of cannabinoids in a selected C5-C7 hydrocarbon solvent, adding thereto a selected amine to thereby precipitate a THCA-amine salt therefrom, dissolving the recovered THCA-amine salt in a selected solvent and then adding thereto a selected antisolvent to thereby recrystallize a purified THCA-amine salt therefrom. The recrystallized THCA-amine salt may be decarboxylated to form a mixture of Δ9-tetrahydrocannabinol (Δ9-THC) and amine. The Δ9-THC amine mixture may be acidified to separate the amine from Δ9-THC. The recovered Δ9-THC may be concentrated to produce a highly purified Δ9-THC. Also disclosed are THCA-amine salts produced with amines selected from groups of diamines, amino alcohols, and tertiary amines.

Described herein are multi-functionalized hollow fiber organocatalysts, processes for producing multi-functionalized hollow fiber organocatalysts, and processes that utilize multi-functionalized hollow fiber organocatalysts for reacting chemicals. A variety of chemical reactions may be enhanced with the multifunctional hollow fiber organocatalysts. The multi-functionalized hollow fiber organocatalysts are particularly advantageous when used as heterogeneous organocatalysts and continuous-flow reactors.

Described herein are multi-functionalized hollow fiber organocatalysts, processes for producing multi-functionalized hollow fiber organocatalysts, and processes that utilize multi-functionalized hollow fiber organocatalysts for reacting chemicals. A variety of chemical reactions may be enhanced with the multifunctional hollow fiber organocatalysts. The multi-functionalized hollow fiber organocatalysts are particularly advantageous when used as heterogeneous organocatalysts and continuous-flow reactors.

A composition comprising a non-cationic amine epoxide adduct is disclosed, along with methods of making the same. Use of a composition comprising a non-cationic amine epoxide adduct on textiles and paper, particularly woven textiles, tissues, and nonwoven textiles to soften the textiles and paper, along with methods of using a non-cationic amine epoxide adduct to treat a target, are also disclosed.

The present invention relates to a process for recrystallizing piroctone olamine, to a process for preparing piroctone olamine crystals and to piroctone olamine crystals which may be obtained by such processes.

Compounds are provided having the following structure: Formula (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R, R.sup.1, R.sup.2, G.sup.1, G.sup.2 and n are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided. ##STR00001##